Cargando…

SHC1 Promotes Lung Cancer Metastasis by Interacting with EGFR

The study aims to explore the biological function of SHC1 in the development and progression of lung cancer. Meanwhile, the effect of SHC1 and EGFR on lung cancer was analyzed. The expression of SHC1 in lung cancer and adjacent tissues was analyzed by bioinformatics and immunohistochemistry. Meanwhi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Pan, Li, Wei, Li, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192283/ https://www.ncbi.nlm.nih.gov/pubmed/35706930 http://dx.doi.org/10.1155/2022/3599832

Ejemplares similares

Targeting the Shc-EGFR interaction with indomethacin inhibits MAP kinase pathway signalling
por: Lin, Chi-Chuan, et al.
Publicado: (2019)

p66ShcA functions as a contextual promoter of breast cancer metastasis
por: Lewis, Kyle, et al.
Publicado: (2020)

Pan-Cancer Study of SHC-Adaptor Protein 1 (SHC1) as a Diagnostic, Prognostic and Immunological Biomarker in Human Cancer
por: Chen, Jianlin, et al.
Publicado: (2022)

SHC4 promotes tumor proliferation and metastasis by activating STAT3 signaling in hepatocellular carcinoma
por: Zhang, Xin, et al.
Publicado: (2022)

IQGAP3 Promotes EGFR-ERK Signaling and the Growth and Metastasis of Lung Cancer Cells
por: Yang, Ying, et al.
Publicado: (2014)

The role of the ShcD and RET interaction in neuroblastoma survival and migration
por: Mabruk, Zeanap A., et al.
Publicado: (2018)

ATHEROSCLEROSIS NEEDS SHC
por: Robinson, Richard
Publicado: (2008)

ShcD Binds DOCK4, Promotes Ameboid Motility and Metastasis Dissemination, Predicting Poor Prognosis in Melanoma
por: Aladowicz, Ewa, et al.
Publicado: (2020)

Human SHC‐transforming protein 1 and its isoforms p66shc: A novel marker for prediabetes
por: Jelinek, Herbert F, et al.
Publicado: (2021)

Localization of phosphotyrosine adaptor protein ShcD/SHC4 in the adult rat central nervous system
por: Robeson, Hannah N., et al.
Publicado: (2019)

p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapy
por: Frackelton, A Raymond, et al.
Publicado: (2006)

STAMBP promotes lung adenocarcinoma metastasis by regulating the EGFR/MAPK signaling pathway
por: Xu, Hui, et al.
Publicado: (2021)

Negative feedback loop between p66(Shc) and ZEB1 regulates fibrotic EMT response in lung cancer cells
por: Li, X, et al.
Publicado: (2015)

Stanniocalcin 1 promotes lung metastasis of breast cancer by enhancing EGFR–ERK–S100A4 signaling
por: Liu, Anfei, et al.
Publicado: (2023)

PELI1 and EGFR cooperate to promote breast cancer metastasis
por: Qi, Jie, et al.
Publicado: (2023)

P66Shc (Shc1) Zebrafish Mutant Line as a Platform for Testing Decreased Reactive Oxygen Species in Pathology
por: Haslem, Landon, et al.
Publicado: (2022)

Lower p66Shc promoter methylation in subjects with chronic renal failure
por: Hamdi, Radhia, et al.
Publicado: (2021)

P66Shc expression in diabetic rat retina
por: Zhao, Ming-Hui, et al.
Publicado: (2018)

Sos-mediated activation of rac1 by p66shc
por: Khanday, Firdous A., et al.
Publicado: (2006)

EGFR-phosphorylated GDH1 harmonizes with RSK2 to drive CREB activation and tumor metastasis in EGFR-activated lung cancer
por: Kang, JiHoon, et al.
Publicado: (2022)

TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target
por: Yu, Jiao-jiao, et al.
Publicado: (2020)

Identification of Peroxiredoxin 1 as a novel interaction partner for the lifespan regulator protein p66Shc
por: Gertz, Melanie, et al.
Publicado: (2009)

Shc3 promotes hepatocellular carcinoma stemness and drug resistance by interacting with β-catenin to inhibit its ubiquitin degradation pathway
por: Liu, Yun, et al.
Publicado: (2021)

The Shc1 adaptor simultaneously balances Stat1 and Stat3 activity to promote breast cancer immune suppression
por: Ahn, Ryuhjin, et al.
Publicado: (2017)

Targeting MCT-1 oncogene inhibits Shc pathway and xenograft tumorigenicity
por: Shih, Hung-Ju, et al.
Publicado: (2012)

The increased expression and aberrant methylation of SHC1 in non–small cell lung cancer: Integrative analysis of clinical and bioinformatics databases
por: Liang, Yicheng, et al.
Publicado: (2021)

p66Shc in Cardiovascular Pathology
por: Haslem, Landon, et al.
Publicado: (2022)

P66Shc signals to age
por: Trinei, Mirella, et al.
Publicado: (2009)

The neuronal Shc adaptor in Alzheimer’s Disease
por: Triaca, Viviana, et al.
Publicado: (2018)

Insights into the Shc Family of Adaptor Proteins
por: Ahmed, Samrein B. M., et al.
Publicado: (2017)

The p52 isoform of SHC1 is a key driver of breast cancer initiation
por: Wright, Kevin D., et al.
Publicado: (2019)

CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation
por: Chang, C-C, et al.
Publicado: (2013)

P66SHC and Ageing: ROS and TOR?
por: Pani, Giovambattista
Publicado: (2010)

Mitochondrial translocation of EGFR regulates mitochondria dynamics and promotes metastasis in NSCLC
por: Che, Ting-Fang, et al.
Publicado: (2015)

Synchronous Multiple Lung Cancers with Lymph Node Metastasis and Different EGFR Mutations: Intrapulmonary Metastasis or Multiple Primary Lung Cancers?
por: Qu, Rirong, et al.
Publicado: (2021)

Akt1 inhibition promotes breast cancer metastasis through EGFR-mediated β-catenin nuclear accumulation
por: Li, Wei, et al.
Publicado: (2018)

Lamin B1 Overexpresses in Lung Adenocarcinoma and Promotes Proliferation in Lung Cancer Cells via AKT Pathway
por: Li, Wei, et al.
Publicado: (2020)

P66Shc and vascular endothelial function
por: Kumar, Santosh
Publicado: (2019)

Non-canonical dynamic mechanisms of interaction between the p66Shc protein and Met receptor
por: Landry, Mélissa, et al.
Publicado: (2016)

Double p52Shc/p46Shc Rat Knockout Demonstrates Severe Gait Abnormalities Accompanied by Dilated Cardiomyopathy
por: Miller, Bradley, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_loq78hp27jhaj97jlul20gv9cn